158 related articles for article (PubMed ID: 34214131)
1. Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
Dickey BL; Sirak B; Martin-Gomez L; Reich RR; Abrahamsen M; Isaacs-Soriano K; Chung CH; Giuliano AR
PLoS One; 2021; 16(7):e0254161. PubMed ID: 34214131
[TBL] [Abstract][Full Text] [Related]
2. Quantification of secretory leukocyte protease inhibitor (SLPI) in oral gargle specimens collected using mouthwash.
Pierce Campbell CM; Guan W; Sprung R; Koomen JM; O'Keefe MT; Ingles DJ; Abrahamsen M; Giuliano AR
J Immunol Methods; 2013 Dec; 400-401():117-21. PubMed ID: 24140751
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
[TBL] [Abstract][Full Text] [Related]
4. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
[TBL] [Abstract][Full Text] [Related]
5. Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort.
Pierce Campbell CM; Giuliano AR; Torres BN; O'Keefe MT; Ingles DJ; Anderson RL; Teras LR; Gapstur SM
Oral Oncol; 2016 Apr; 55():1-5. PubMed ID: 27016010
[TBL] [Abstract][Full Text] [Related]
6. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
[TBL] [Abstract][Full Text] [Related]
7. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
[TBL] [Abstract][Full Text] [Related]
8. Distribution and factors associated with salivary secretory leukocyte protease inhibitor concentrations.
Rahman S; Pierce Campbell CM; Torres BN; O'Keefe MT; Ingles DJ; Villa LL; Carvalho da Silva RJ; Cintra RC; Lazcano-Ponce E; Salmeron J; Quiterio M; Giuliano AR
Oral Dis; 2016 Nov; 22(8):781-790. PubMed ID: 27470907
[TBL] [Abstract][Full Text] [Related]
9. The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma.
Quabius ES; Görögh T; Fischer GS; Hoffmann AS; Gebhard M; Evert M; Beule A; Maune S; Knecht R; Óvári A; Durisin M; Hoppe F; Röcken C; Hedderich J; Ambrosch P; Hoffmann M
Cancer Lett; 2015 Feb; 357(1):339-345. PubMed ID: 25462861
[TBL] [Abstract][Full Text] [Related]
10. Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons.
Chattopadhyay A; Gray LR; Patton LL; Caplan DJ; Slade GD; Tien HC; Shugars DC
Infect Immun; 2004 Apr; 72(4):1956-63. PubMed ID: 15039315
[TBL] [Abstract][Full Text] [Related]
11. Expression of oral secretory leukocyte protease inhibitor in HIV-infected subjects with long-term use of antiretroviral therapy.
Nittayananta W; Kemapunmanus M; Yangngam S; Talungchit S; Sriplung H
J Oral Pathol Med; 2013 Mar; 42(3):208-15. PubMed ID: 23126266
[TBL] [Abstract][Full Text] [Related]
12. Case-control study of human papillomavirus and oropharyngeal cancer.
D'Souza G; Kreimer AR; Viscidi R; Pawlita M; Fakhry C; Koch WM; Westra WH; Gillison ML
N Engl J Med; 2007 May; 356(19):1944-56. PubMed ID: 17494927
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
14. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
Shugars DC; Watkins CA; Cowen HJ
Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
[TBL] [Abstract][Full Text] [Related]
15. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics.
Giuliano AR; Nedjai B; Lorincz AT; Schell MJ; Rahman S; Banwait R; Boulware D; Sirak B; Martin-Gomez L; Abrahamsen M; Isaacs-Soriano KA; Wenig B; Chung CH; Caudell J
Int J Cancer; 2020 Feb; 146(4):1018-1030. PubMed ID: 31304592
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
[TBL] [Abstract][Full Text] [Related]
17. Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer.
Dickey BL; Nedjai B; Preece MD; Schell MJ; Boulware D; Whiting J; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Kennedy K; Chung CH; Giuliano AR
Cancer Med; 2022 Oct; 11(20):3735-3742. PubMed ID: 35619332
[TBL] [Abstract][Full Text] [Related]
18. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
19. Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study.
Laprise C; Madathil SA; Schlecht NF; Castonguay G; Soulières D; Nguyen-Tan PF; Allison P; Coutlée F; Hier M; Rousseau MC; Franco EL; Nicolau B
Head Neck; 2019 Mar; 41(3):678-685. PubMed ID: 30605251
[TBL] [Abstract][Full Text] [Related]
20. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases.
Martin-Gomez L; Fulp WJ; Schell MJ; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Lorincz A; Wenig B; Chung CH; Caudell JJ; Giuliano AR
Oral Oncol; 2019 May; 92():85-91. PubMed ID: 31010629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
